Amoy Diagnostics Co Ltd Class A 300685
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥19.26
- Day Range
- ¥19.50–20.70
- 52-Week Range
- ¥14.60–25.28
- Bid/Ask
- ¥20.28 / ¥20.30
- Market Cap
- ¥8.09 Bil
- Volume/Avg
- 8.1 Mil / 3.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 28.18
- Price/Sales
- 7.16
- Dividend Yield (Trailing)
- 0.74%
- Dividend Yield (Forward)
- 0.74%
- Total Yield
- 0.74%
Company Profile
Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,119
- Website
- http://www.amoydx.com
Comparables
Valuation
|
Metric
|
300685
|
688468
|
603658
|
|---|---|---|---|
Price/Earnings (Normalized) | 28.18 | 18.73 | 19.87 |
Price/Book Value | 4.59 | 1.82 | 3.10 |
Price/Sales | 7.16 | 5.48 | 5.53 |
Price/Cash Flow | 22.07 | 12.83 | 13.96 |
Price/Earnings
300685
688468
603658
Financial Strength
|
Metric
|
300685
|
688468
|
603658
|
|---|---|---|---|
Quick Ratio | 7.70 | 4.71 | 0.99 |
Current Ratio | 7.98 | 5.48 | 2.71 |
Interest Coverage | 272.48 | 111.54 | 57.12 |
Quick Ratio
300685
688468
603658
Profitability
|
Metric
|
300685
|
688468
|
603658
|
|---|---|---|---|
Return on Assets (Normalized) | 13.93% | 7.46% | 11.37% |
Return on Equity (Normalized) | 15.61% | 9.59% | 15.28% |
Return on Invested Capital (Normalized) | 13.94% | 7.98% | 14.14% |
Return on Assets
300685
688468
603658
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Mvctxxvpx | Jqmz | $234.7 Bil | |||
| Danaher Corp
DHR
| Ckbcbqvhdt | Bsqmfw | $198.9 Bil | |||
| IQVIA Holdings Inc
IQV
| Sqbrlctq | Bhwrw | $42.8 Bil | |||
| Agilent Technologies Inc
A
| Swgdnxvx | Qpv | $42.5 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Qmftywmfm | Hbpl | $42.1 Bil | |||
| Mettler-Toledo International Inc
MTD
| Dzzzrkcry | Gdsppg | $31.4 Bil | |||
| Icon PLC
ICLR
| Rxptvmjw | Dnpvv | $23.7 Bil | |||
| Waters Corp
WAT
| Frkwvyjfyw | Jmcf | $21.2 Bil | |||
| Illumina Inc
ILMN
| Tqwzdrly | Jfxljzl | $20.7 Bil | |||
| Labcorp Holdings Inc
LH
| Qdwjdkbrm | Dhdmk | $18.6 Bil |
United States